Quick Answer
Elanco Animal Health Inc reported Research And Development Expense of $368.00 million for the year ending 2025.
- Elanco Animal Health Inc showed an increase of +7.0% in Research And Development Expense from 2024 to 2025.
- This data is from Elanco Animal Health Inc's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), Elanco Animal Health Inc's Research And Development Expense has grown by 38.4%.
- Historical annual values: Fiscal year 2025: $368.00 million | Fiscal year 2024: $344.00 million | Fiscal year 2023: $327.00 million | Fiscal year 2022: $321.00 million | Fiscal year 2021: $369.00 million | Fiscal year 2020: $329.00 million | Fiscal year 2019: $270.00 million | Fiscal year 2018: $246.60 million | Fiscal year 2017: $251.70 million | Fiscal year 2016: $265.80 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: